Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-04-25

FDA Approved: DEFLAZACORT ORAL SUSPENSION — Original Application (Cranbury Pharmaceuticals, LLC)

View source ↗

Summary

FDA approved Deflazacort Oral Suspension from Cranbury Pharmaceuticals as an Original Application (ANDA), providing a generic version of deflazacort for approve…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DEFLAZACORT ORAL SUSPENSION (deflazacort)

Snippet

ORIG AP for DEFLAZACORT ORAL SUSPENSION (DEFLAZACORT ORAL)